SCHEMBL17500118

SCHEMBL17500118

O=Cc1cnn(C2CC(NC(=O)O)C2)c1

nearest known ligand 0.36

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ SMYD3 Q9H7B4 1/20 0.36
▸ ACHE P22303 3/20 0.34
▸ ATM Q13315 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.30
▸ LMNA P02545 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ OPRK1 P41145 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17500115 1.00 SMYD3 (0.36) SMYD3ACHEATMALDH1A1LMNA
SCHEMBL17374313 0.82 KMT2A (0.46) —
SCHEMBL26601146 0.79 SMYD3 (0.37) SMYD3ACHEOPRK1
SCHEMBL26601141 0.79 SMYD3 (0.37) SMYD3ACHEOPRK1
SCHEMBL21410750 0.77 ACHE (0.37) ACHE
SCHEMBL17500142 0.77 SMYD3 (0.36) SMYD3ACHELMNAOPRK1
SCHEMBL17500144 0.77 SMYD3 (0.36) SMYD3ACHELMNAOPRK1
SCHEMBL31115833 0.75 ACHE (0.36) ACHE
SCHEMBL17874277 0.75 PSMB8 (0.35) SMYD3ACHE
SCHEMBL21410602 0.75 ACHE (0.39) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017040606-A1 ISOXAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF PULMONARY DISEASES AND DISORDERS PROTEOSTASIS THERAPEUTICS, INC. (US) 2017-03-09 — — WO disclosed
WO-2016115090-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR INCREASING CFTR ACTIVITY PROTEOSTASIS THERAPEUTICS, INC. (US) 2016-07-21 — — WO disclosed
WO-2015196071-A9 COMPOUNDS, COMPOSITIONS AND METHODS OF INCREASING CFTR ACTIVITY PROTEOSTASIS THERAPEUTICS, INC. (US) 2016-02-18 — — WO disclosed
Send feedback